Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James L Goodson

Showing results (131-140 of 142) with videos related to

Pageof 15
Sort By:
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 29, 2016
Measles immunity among pregnant women aged 15-44 years in Namibia, 2008 and 2010Cristina V Cardemil, Anna Jonas, Anita Beukes, et al.
Journal of Clinical Microbiology|March 1, 2019
Use of FTA Cards To Transport Throat Swabs and Oral Fluid Samples for Molecular Detection and Genotyping of Measles and Rubella VirusesBettina Bankamp, Carolyn Sein, Elisabeth Pukuta Simbu, et al.
Vaccines|August 29, 2024
Use of Measles and Rubella Rapid Diagnostic Tests to Improve Case Detection and Targeting of VaccinationsAudrey Rachlin, Lee M Hampton, Paul A Rota, et al.
MMWR. Morbidity and Mortality Weekly Report|April 5, 2014
Progress toward measles preelimination--African Region, 2011-2012Balcha G Masresha, Reinhard Kaiser, Messeret Eshetu, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|May 16, 2015
Development of a District-Level Programmatic Assessment Tool for Risk of Measles Virus TransmissionEugene Lam, W William Schluter, Balcha G Masresha, et al.
MMWR. Morbidity and Mortality Weekly Report|March 4, 2016
Progress Toward Measles Elimination - Nepal, 2007-2014Sudhir Khanal, Tika Ram Sedai, Ganga Ram Choudary, et al.
Trials|September 14, 2022
Study protocol for a phase 1/2, single-centre, double-blind, double-dummy, randomized, active-controlled, age de-escalation trial to assess the safety, tolerability and immunogenicity of a measles and rubella vaccine delivered by a microneedle patch in healthy adults (18 to 40 years), measles and rubella vaccine-primed toddlers (15 to 18 months) and measles and rubella vaccine-naïve infants (9 to 10 months) in The Gambia [Measles and Rubella Vaccine Microneedle Patch Phase 1/2 Age De-escalation Trial]Ikechukwu Adigweme, Edem Akpalu, Mohammed Yisa, et al.
Journal of Clinical Microbiology|March 18, 2021
Development of a Measles and Rubella Multiplex Bead Serological Assay for Assessing Population ImmunityMelissa M Coughlin, Zachary Matson, Sun B Sowers, et al.
The Journal of Infectious Diseases|March 30, 2019
Increase in Infant Measles Deaths During a Nationwide Measles Outbreak-Mongolia, 2015-2016Christopher T Lee, Jose E Hagan, Baigalmaa Jantsansengee, et al.
MMWR. Morbidity and Mortality Weekly Report|May 6, 2016
Global Measles and Rubella Laboratory Network Support for Elimination Goals, 2010-2015Mick N Mulders, Paul A Rota, Joseph P Icenogle, et al.
Pageof 15

Showing results (131-140 of 142) with videos related to

Sort By:
Pageof 15
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 29, 2016
Measles immunity among pregnant women aged 15-44 years in Namibia, 2008 and 2010Cristina V Cardemil, Anna Jonas, Anita Beukes, et al.
Journal of Clinical Microbiology|March 1, 2019
Use of FTA Cards To Transport Throat Swabs and Oral Fluid Samples for Molecular Detection and Genotyping of Measles and Rubella VirusesBettina Bankamp, Carolyn Sein, Elisabeth Pukuta Simbu, et al.
Vaccines|August 29, 2024
Use of Measles and Rubella Rapid Diagnostic Tests to Improve Case Detection and Targeting of VaccinationsAudrey Rachlin, Lee M Hampton, Paul A Rota, et al.
MMWR. Morbidity and Mortality Weekly Report|April 5, 2014
Progress toward measles preelimination--African Region, 2011-2012Balcha G Masresha, Reinhard Kaiser, Messeret Eshetu, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|May 16, 2015
Development of a District-Level Programmatic Assessment Tool for Risk of Measles Virus TransmissionEugene Lam, W William Schluter, Balcha G Masresha, et al.
MMWR. Morbidity and Mortality Weekly Report|March 4, 2016
Progress Toward Measles Elimination - Nepal, 2007-2014Sudhir Khanal, Tika Ram Sedai, Ganga Ram Choudary, et al.
Trials|September 14, 2022
Study protocol for a phase 1/2, single-centre, double-blind, double-dummy, randomized, active-controlled, age de-escalation trial to assess the safety, tolerability and immunogenicity of a measles and rubella vaccine delivered by a microneedle patch in healthy adults (18 to 40 years), measles and rubella vaccine-primed toddlers (15 to 18 months) and measles and rubella vaccine-naïve infants (9 to 10 months) in The Gambia [Measles and Rubella Vaccine Microneedle Patch Phase 1/2 Age De-escalation Trial]Ikechukwu Adigweme, Edem Akpalu, Mohammed Yisa, et al.
Journal of Clinical Microbiology|March 18, 2021
Development of a Measles and Rubella Multiplex Bead Serological Assay for Assessing Population ImmunityMelissa M Coughlin, Zachary Matson, Sun B Sowers, et al.
The Journal of Infectious Diseases|March 30, 2019
Increase in Infant Measles Deaths During a Nationwide Measles Outbreak-Mongolia, 2015-2016Christopher T Lee, Jose E Hagan, Baigalmaa Jantsansengee, et al.
MMWR. Morbidity and Mortality Weekly Report|May 6, 2016
Global Measles and Rubella Laboratory Network Support for Elimination Goals, 2010-2015Mick N Mulders, Paul A Rota, Joseph P Icenogle, et al.
Pageof 15